BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8706082)

  • 1. [Hyperhomocysteinemia].
    Sobra J
    Cas Lek Cesk; 1996 May; 135(9):266-9. PubMed ID: 8706082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics of hyperhomocysteinaemia in cardiovascular disease.
    Lievers KJ; Kluijtmans LA; Blom HJ
    Ann Clin Biochem; 2003 Jan; 40(Pt 1):46-59. PubMed ID: 12542910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.
    Booth GL; Wang EE
    CMAJ; 2000 Jul; 163(1):21-9. PubMed ID: 10920726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homocysteine threshold value based on cystathionine beta synthase and paraoxonase 1 activities in mice.
    Hamelet J; Aït-Yahya-Graison E; Matulewicz E; Noll C; Badel-Chagnon A; Camproux AC; Demuth K; Paul JL; Delabar JM; Janel N
    Eur J Clin Invest; 2007 Dec; 37(12):933-8. PubMed ID: 17971175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperhomocysteinemia: an additional cardiovascular risk factor.
    Fanapour PC; Yug B; Kochar MS
    WMJ; 1999 Dec; 98(8):51-4. PubMed ID: 10639897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteine: evidence for a causal relationship with cardiovascular disease.
    Scott CH; Sutton MS
    Cardiol Rev; 1999; 7(2):101-7. PubMed ID: 10348972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel risk factors for vascular disease: the homocysteine hypothesis of cardiovascular disease.
    Wilcken DE
    J Cardiovasc Risk; 1998 Aug; 5(4):217-21. PubMed ID: 9919468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Homocysteine metabolism and risk of cardiovascular diseases: importance of the nutritional status on folic acid, vitamins B6 and B12].
    Alemán G; Tovar AR; Torres N
    Rev Invest Clin; 2001; 53(2):141-51. PubMed ID: 11421110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hiperhomocysteinemia in active and passive smokers and the levels of folate and vitamin B6 in plasma].
    Marszałł ML; Makarowski R; Hinc S; Kłos M; Czarnowski W
    Przegl Lek; 2008; 65(10):486-90. PubMed ID: 19189529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in the CBS gene associated with decreased risk of coronary artery disease and increased responsiveness to total homocysteine lowering by folic acid.
    Kruger WD; Evans AA; Wang L; Malinow MR; Duell PB; Anderson PH; Block PC; Hess DL; Graf EE; Upson B
    Mol Genet Metab; 2000 May; 70(1):53-60. PubMed ID: 10833331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of hyper-homocysteinemia in the etiology of some vascular diseases].
    Czeizel E; Matos L
    Orv Hetil; 1998 Sep; 139(37):2191-6. PubMed ID: 9769688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Homocysteine and hyperhomocysteinemia].
    Laskowska-Klita T
    Pol Merkur Lekarski; 2001 Mar; 10(57):135-7. PubMed ID: 11398509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Homocysteine. The cardiovascular risk factor of the next millennium?].
    Suárez García I; Gómez Cerezo JF; Ríos Blanco JJ; Barbado Hernández FJ; Vázquez Rodríguez JJ
    An Med Interna; 2001 Apr; 18(4):211-7. PubMed ID: 11496543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperhomocysteinemia in coronary artery diseases. Apropos of a study on 102 patients].
    Blacher J; Montalescot G; Ankri A; Chadefaux-Vekemans B; Benzidia R; Grosgogeat Y; Kamoun P; Thomas D
    Arch Mal Coeur Vaiss; 1996 Oct; 89(10):1241-6. PubMed ID: 8952820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Homocysteine--a routine biochemical parameter in cardiovascular diseases?].
    Gábor D; Hrnciar J; Hricová I; Zacharová M
    Vnitr Lek; 1999 Jan; 45(1):40-5. PubMed ID: 10422525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperhomocysteinemia as a cardiovascular risk factor in Indian women: determinants and directionality.
    Pandey SN; Vaidya AD; Vaidya RA; Talwalkar S
    J Assoc Physicians India; 2006 Oct; 54():769-74. PubMed ID: 17214272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 31 bp VNTR in the cystathionine beta-synthase (CBS) gene is associated with reduced CBS activity and elevated post-load homocysteine levels.
    Lievers KJ; Kluijtmans LA; Heil SG; Boers GH; Verhoef P; van Oppenraay-Emmerzaal D; den Heijer M; Trijbels FJ; Blom HJ
    Eur J Hum Genet; 2001 Aug; 9(8):583-9. PubMed ID: 11528503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylenetetrahydrofolate reductase gene mutation and hyperhomocysteinemia as a risk factor for coronary heart disease in the Indian population.
    Nair KG; Nair SR; Ashavaid TF; Dalal JJ; Eghlim FF
    J Assoc Physicians India; 2002 May; 50 Suppl():9-15. PubMed ID: 12186157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [From gene to disease; from homocysteine to hyperhomocysteinemia].
    Boers GH
    Ned Tijdschr Geneeskd; 2001 May; 145(20):956-8. PubMed ID: 11396261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.